Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Blenrep (Belantamab Mafodotin) Covered by Blue Cross Blue Shield in Virginia: Current Access Options and Appeals Guide

Answer Box: Blenrep Coverage in Virginia Blenrep (belantamab mafodotin) is not commercially available in the U.S. as of 2025 due to GSK's voluntary withdrawal in 2022 pending FDA resubmission (PDUFA target October 2025). Current access is limited to clinical trials or expanded access programs only. For Blue

How to Get Dupixent (dupilumab) Covered by Blue Cross Blue Shield in Ohio: Prior Authorization, Appeals, and Step Therapy Override Guide

Answer Box: Getting Dupixent Covered in Ohio Blue Cross Blue Shield (primarily Anthem) in Ohio requires prior authorization for Dupixent (dupilumab) with step therapy requirements varying by indication. Ohio's step therapy override law (ORC §3901.832) requires approval within 72 hours if you've failed preferred treatments

Getting Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in California: Complete Coding, Appeals, and Authorization Guide

Quick Answer: Getting Strimvelis Covered by Blue Cross Blue Shield in California Blue Cross Blue Shield plans in California require prior authorization for Strimvelis (autologous CD34+ gene therapy for ADA-SCID), administered only at SR-TIGET in Milan, Italy. Use ICD-10 code D81.31 (severe combined immunodeficiency due to adenosine deaminase deficiency)

The Requirements Checklist to Get Poteligeo (mogamulizumab-kpkc) Covered by Blue Cross Blue Shield in North Carolina: Forms, Appeals, and Documentation Guide

Answer Box: Fast Track to Poteligeo Coverage To get Poteligeo (mogamulizumab-kpkc) covered by Blue Cross Blue Shield in North Carolina: 1) Confirm your plan requires prior authorization through the Blue Cross NC provider portal, 2) Submit PA with documented relapsed/refractory mycosis fungoides or Sézary syndrome after ≥1 prior systemic

How to Get Lutathera Covered by Blue Cross Blue Shield in California: Complete Forms, Portal & Appeals Guide

Answer Box: Getting Lutathera Approved by Blue Cross Blue Shield California Blue Cross Blue Shield California requires prior authorization for Lutathera (lutetium Lu-177 dotatate) as a medical benefit drug for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Submit requests via your oncologist through the AuthAccel online system or contact Evolent at

Work With Your Doctor to Get Cystadane (Betaine Anhydrous) Approved by Blue Cross Blue Shield in Washington: Complete Provider Collaboration Guide

Answer Box: Getting Cystadane Covered Through Provider Partnership Blue Cross Blue Shield requires prior authorization for Cystadane with genetic confirmation, vitamin therapy trials, and specialist involvement. Success depends on strong provider collaboration: gather genetic testing results and homocysteine labs (>100 μmol/L), document failed vitamin B6/B12/folate trials,

Myths vs. Facts: Getting iLink® Corneal Cross-Linking Covered by Blue Cross Blue Shield in Washington

Answer Box: iLink® Coverage by Blue Cross Blue Shield in Washington Regence Blue Cross Blue Shield and Premera Blue Cross in Washington cover FDA-approved iLink® corneal cross-linking for progressive keratoconus with prior authorization. The fastest path to approval requires documenting disease progression (≥1.0 diopter Kmax increase over 6-12 months)

How Long Does It Take to Get Vyondys 53 (golodirsen) Approved by Blue Cross Blue Shield in New York? Timeline & Appeal Process

Answer Box: Getting Vyondys 53 Approved in New York Getting Vyondys 53 (golodirsen) approved by Blue Cross Blue Shield in New York typically takes 5-14 business days for standard requests, with expedited reviews possible in 24-48 hours for urgent cases. The fastest path requires: (1) genetic testing confirming exon 53

How to Get Joenja (leniolisib) Covered by Blue Cross Blue Shield in Ohio: Complete PA Guide and Appeal Scripts

Answer Box: Getting Joenja (leniolisib) Covered by Blue Cross Blue Shield in Ohio Joenja (leniolisib) requires prior authorization from Blue Cross Blue Shield plans in Ohio. The fastest path to approval: (1) Confirm genetic testing proves APDS (PIK3CD or PIK3R1 variants), (2) Have your immunologist submit PA via Anthem'

How to Get Rezlidhia (olutasidenib) Covered by Blue Cross Blue Shield of Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Rezlidhia Covered by Blue Cross Blue Shield Illinois Blue Cross Blue Shield of Illinois (BCBSIL) requires prior authorization for Rezlidhia (olutasidenib) with documented IDH1 mutation testing and oncology monitoring plan. Submit through their provider portal with FDA-approved mutation results, treatment history, and differentiation syndrome monitoring protocol. BCBSIL